Clearance of Apoptotic Neurons Without Inflammation by Microglial Triggering Receptor Expressed on Myeloid Cells-2

Overview

Journal J Exp Med

Specialties Allergy & Immunology
General Medicine

Date 2005 Feb 25

PMID 15728241

Citations 551

Authors

Kazuya Takahashi

Christian D P Rochford

Harald Neumann

Affiliations

Soon will be listed here.

Abstract

Elimination of apoptotic neurons without inflammation is crucial for brain tissue homeostasis, but the molecular mechanism has not been firmly established. Triggering receptor expressed on myeloid cells-2 (TREM2) is a recently identified innate immune receptor. Here, we show expression of TREM2 in microglia. TREM2 stimulation induced DAP12 phosphorylation, extracellular signal-regulated kinase phosphorylation, and cytoskeleton reorganization and increased phagocytosis. Knockdown of TREM2 in microglia inhibited phagocytosis of apoptotic neurons and increased gene transcription of tumor necrosis factor alpha and nitric oxide synthase-2, whereas overexpression of TREM2 increased phagocytosis and decreased microglial proinflammatory responses. Thus, TREM2 deficiency results in impaired clearance of apoptotic neurons and inflammation that might be responsible for the brain degeneration observed in patients with polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy/Nasu-Hakola disease.

Citing Articles

RhoA/ROCK/GSK3β Signaling: A Keystone in Understanding Alzheimer's Disease.

Medd M, Yon J, Dong H Curr Issues Mol Biol. 2025; 47(2).

PMID: 39996845 PMC: 11854763. DOI: 10.3390/cimb47020124.

Modulating Neuroinflammation as a Prospective Therapeutic Target in Alzheimer's Disease.

Lee E, Chang Y Cells. 2025; 14(3).

PMID: 39936960 PMC: 11817173. DOI: 10.3390/cells14030168.

Extracellular domain of TREM2 possess two distinct ligand recognition sites: Insights from machine-learning guided docking and all-atoms molecular dynamics simulations.

Mishra S, Swain P, Pati S, Dehury B Heliyon. 2025; 11(1):e41414.

PMID: 39866401 PMC: 11759634. DOI: 10.1016/j.heliyon.2024.e41414.

Xixin Decoction's novel mechanism for alleviating Alzheimer's disease cognitive dysfunction by modulating amyloid-β transport across the blood-brain barrier to reduce neuroinflammation.

Yang C, Zhao E, Zhang H, Duan L, Han X, Ding H Front Pharmacol. 2025; 15():1508726.

PMID: 39834810 PMC: 11743276. DOI: 10.3389/fphar.2024.1508726.

SIX1 aggravates the progression of spinal cord injury in mice by promoting M1 polarization of microglia.

Xu Z, Zhu M, Xie H, Zhu J, Zheng H, Liu X Sci Rep. 2025; 15(1):1283.

PMID: 39779741 PMC: 11711668. DOI: 10.1038/s41598-024-82121-3.

References

Paloneva J, Kestila M, Wu J, Salminen A, Bohling T, Ruotsalainen V . Loss-of-function mutations in TYROBP (DAP12) result in a presenile dementia with bone cysts. Nat Genet. 2000; 25(3):357-61. DOI: 10.1038/77153. View

Mack K, Wei R, Elbagarri A, Abbey N, McGrath M . A novel method for DEAE-dextran mediated transfection of adherent primary cultured human macrophages. J Immunol Methods. 1998; 211(1-2):79-86. DOI: 10.1016/s0022-1759(97)00194-4. View

Tomasello E, Desmoulins P, Chemin K, Guia S, Cremer H, Ortaldo J . Combined natural killer cell and dendritic cell functional deficiency in KARAP/DAP12 loss-of-function mutant mice. Immunity. 2000; 13(3):355-64. DOI: 10.1016/s1074-7613(00)00035-2. View

Cocco R, Ucker D . Distinct modes of macrophage recognition for apoptotic and necrotic cells are not specified exclusively by phosphatidylserine exposure. Mol Biol Cell. 2001; 12(4):919-30. PMC: 32276. DOI: 10.1091/mbc.12.4.919. View

Paloneva J, Autti T, Raininko R, Partanen J, Salonen O, Puranen M . CNS manifestations of Nasu-Hakola disease: a frontal dementia with bone cysts. Neurology. 2001; 56(11):1552-8. DOI: 10.1212/wnl.56.11.1552. View

Bouchon A, Cella M, Colonna M . A DAP12-mediated pathway regulates expression of CC chemokine receptor 7 and maturation of human dendritic cells. J Exp Med. 2001; 194(8):1111-22. PMC: 2193511. DOI: 10.1084/jem.194.8.1111. View

Neumann H, Schweigreiter R, Yamashita T, Rosenkranz K, Wekerle H, Barde Y . Tumor necrosis factor inhibits neurite outgrowth and branching of hippocampal neurons by a rho-dependent mechanism. J Neurosci. 2002; 22(3):854-62. PMC: 6758473. View

Paloneva J, Manninen T, Christman G, Hovanes K, Mandelin J, Adolfsson R . Mutations in two genes encoding different subunits of a receptor signaling complex result in an identical disease phenotype. Am J Hum Genet. 2002; 71(3):656-62. PMC: 379202. DOI: 10.1086/342259. View

Lucas M, Daniel L, Tomasello E, Guia S, Horschowski N, Aoki N . Massive inflammatory syndrome and lymphocytic immunodeficiency in KARAP/DAP12-transgenic mice. Eur J Immunol. 2002; 32(9):2653-63. DOI: 10.1002/1521-4141(200209)32:9<2653::AID-IMMU2653>3.0.CO;2-V. View

10.

Kondo T, Takahashi K, Kohara N, Takahashi Y, Hayashi S, Takahashi H . Heterogeneity of presenile dementia with bone cysts (Nasu-Hakola disease): three genetic forms. Neurology. 2002; 59(7):1105-7. DOI: 10.1212/wnl.59.7.1105. View

11.

Savill J, Dransfield I, Gregory C, Haslett C . A blast from the past: clearance of apoptotic cells regulates immune responses. Nat Rev Immunol. 2002; 2(12):965-75. DOI: 10.1038/nri957. View

12.

Schmid C, Sautkulis L, Danielson P, Cooper J, Hasel K, Hilbush B . Heterogeneous expression of the triggering receptor expressed on myeloid cells-2 on adult murine microglia. J Neurochem. 2002; 83(6):1309-20. PMC: 2637869. DOI: 10.1046/j.1471-4159.2002.01243.x. View

13.

Perry V, Newman T, Cunningham C . The impact of systemic infection on the progression of neurodegenerative disease. Nat Rev Neurosci. 2003; 4(2):103-12. DOI: 10.1038/nrn1032. View

14.

Kaifu T, Nakahara J, Inui M, Mishima K, Momiyama T, Kaji M . Osteopetrosis and thalamic hypomyelinosis with synaptic degeneration in DAP12-deficient mice. J Clin Invest. 2003; 111(3):323-32. PMC: 151867. DOI: 10.1172/JCI16923. View

15.

Rubinson D, Dillon C, Kwiatkowski A, Sievers C, Yang L, Kopinja J . A lentivirus-based system to functionally silence genes in primary mammalian cells, stem cells and transgenic mice by RNA interference. Nat Genet. 2003; 33(3):401-6. DOI: 10.1038/ng1117. View

16.

Rosenberger C, Finlay B . Phagocyte sabotage: disruption of macrophage signalling by bacterial pathogens. Nat Rev Mol Cell Biol. 2003; 4(5):385-96. DOI: 10.1038/nrm1104. View

17.

Colonna M . TREMs in the immune system and beyond. Nat Rev Immunol. 2003; 3(6):445-53. DOI: 10.1038/nri1106. View

18.

Smith K, Lassmann H . The role of nitric oxide in multiple sclerosis. Lancet Neurol. 2003; 1(4):232-41. DOI: 10.1016/s1474-4422(02)00102-3. View

19.

Cella M, Buonsanti C, Strader C, Kondo T, Salmaggi A, Colonna M . Impaired differentiation of osteoclasts in TREM-2-deficient individuals. J Exp Med. 2003; 198(4):645-51. PMC: 2194167. DOI: 10.1084/jem.20022220. View

20.

Paloneva J, Mandelin J, Kiialainen A, Bohling T, Prudlo J, Hakola P . DAP12/TREM2 deficiency results in impaired osteoclast differentiation and osteoporotic features. J Exp Med. 2003; 198(4):669-75. PMC: 2194176. DOI: 10.1084/jem.20030027. View